SBRT: Clinical Trials

3 trials for SBRT, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown. 3 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Unknown 3
Phase 31Unknown 1

Follow SBRT: new trials by email Literature Review of SBRT trials Research Report on SBRT

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Lung Perfusion PET / CT Using Ga68-MAA for Preservation of Lung Function During Stereotactic Pulmonary Radiation Therapy
Pre-therapeutic imaging test - SBRT, Non-small Cell Lung Cancer
Phase 2 / Phase 3UnknownUniversity Hospital, Brest602021-07-152022-09-19
Combination of Sintilimab and Stereotactic Body Radiotherapy in Advanced Metastatic HCC
Stereotactic body radiation therapy, Anti-PD-1 antibody drug named Sintilimab - Stage IV HCC, Immunotherapy
Phase 2UnknownWest China Hospital842020-07-012020-09-14
SBRT in Multi-metastatic NSCLC Patients Which Are Pan-negative for Driver Mutations
SBRT concurrent with GM-CSF, two-drug chemotherapy containing platinum, including carboplatin/Cisplatin + pemetrexed/docetaxel/paclitaxel/etoposide/gemcitabine/vinorelbine/albumin-bound paclitaxel - NSCLC, SBRT
Phase 2UnknownShanghai Chest Hospital502016-11-012016-12-01

Narrower conditions

Carcinoma, Non-Small-Cell Lung (1)  ·  Lung Neoplasms (1)

Broader conditions

Bronchial Neoplasms (1)  ·  Carcinoma, Bronchogenic (1)  ·  Lung Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Neoplasms (1)  ·  Thoracic Neoplasms (1)

Interventions

Cisplatin (1)  ·  Granulocyte-Macrophage Colony-Stimulating Factor (1)  ·  Radiosurgery (1)

Sponsors

Shanghai Chest Hospital (1)  ·  University Hospital, Brest (1)  ·  West China Hospital (1)

Countries

China (2)  ·  France (1)

Results publications

PMID 22560555, PMID 26095785, PMID 26484629, PMID 26582738, PMID 26951040, PMID 40591115